This is read by an automated voice. Please report any issues or inconsistencies here. Post-production jobs are fleeing California, and workers are calling for a dedicated tax incentive to boost the ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Late in 2025, WPP reported a 5.9% drop in revenue less pass-through costs fell for Q3. Company executives said at the time that greater simplification and new marketing services models are among the ...

Introducing the highest U.S. tariffs since the Great Depression, President Donald Trump made a clear promise in the spring: “Jobs and factories will come roaring back into our country.” They haven’t.

The maker of Jim Beam bourbon whiskey said it plans to pause production at its main distillery in Kentucky starting Jan. 1. Jim Beam, which is owned by a U.S. subsidiary of Japan's Suntory Holdings, ...

Popular Kentucky bourbon maker Jim Beam plans to pause production at its main distillery on January 1, according to the James B. Beam Distilling Co. The decision comes as Kentucky faces an increasing ...

As competing states expand incentives, California’s lack of support for commercial advertising is weakening its creative infrastructure. Unsplash+ California’s creative economy is at a crossroads. Gov ...

Industrial output in the U.S. increased in September, partially retracing an August slump, the Federal Reserve said Wednesday. In September, output of U.S. industry grew by 0.1%, after by falling by 0 ...

Producing and starring in a buzzy documentary about her prominent yet under-the-radar life was just the beginning for Melania Trump, who has now launched her own production company. The first lady ...

With a $140 million investment, Moderna will bring its drug product manufacturing to the United States, joining a parade of drugmakers looking to strengthen their supply chains and reduce exposure to ...

In a bid to deepen its manufacturing foothold in the U.S., Regeneron Pharmaceuticals in April pledged production and infrastructure investments surpassing $7 billion across North Carolina and its ...